Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Automated System Identifies Dense Breast Tissue

By HospiMedica International staff writers
Posted on 29 Oct 2018
A deep-learning (DL) automated model can assess dense breast tissue in mammograms as reliably as expert radiologists, claims a new study.

Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) and Harvard Medical School (HMS; Boston, MA, USA), the DL model is based on a deep convolutional neural network (CNN) trained to assess breast imaging reporting and data system (BI-RADS) breast density--i.e. More...
fatty, scattered, heterogeneous, and dense--based on the expert interpretation of 41,479 digital screening mammograms obtained in 27,684 women from January 2009 to May 2011. The algorithm was then tested on a held-out test set of 8,677 mammograms in 5,741 women.

In addition, five radiologists performed a reader study on 500 mammograms randomly selected from the test set. Finally, the algorithm was implemented in routine clinical practice, where eight radiologists reviewed 10,763 consecutive mammograms assessed with the model. Agreement on BI-RADS category was compared for three sets of readings: radiologists in the test set, radiologists working in consensus in the reader study set, and radiologists in the clinical implementation set. The readings were compared across 5,000 bootstrap samples to assess significance.

The results revealed that the DL model showed good agreement with radiologists in the test set, and with radiologists in consensus in the reader study set. In addition, there was very good agreement with the radiologists in the clinical implementation set; for binary categorization of dense or non-dense breasts, 10,149 of 10,763 (94%) of DL assessments were accepted by the interpreting radiologist. On all four BI-RADS categories, the DL algorithm matched radiologists' assessments at 90%. The study was published on October 16, 2018, in Radiology.

“Breast density is an independent risk factor that drives how we communicate with women about their cancer risk. Our motivation was to create an accurate and consistent tool that can be shared and used across health care systems,” said study author PhD student Adam Yala, of the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL). “When radiologists pull up a scan at their workstations, they'll see the model's assigned rating, which they then accept or reject. It takes less than a second per image ... [and it can be] easily and cheaply scaled throughout hospitals.”

It is estimated that more than 40% of women have dense breast tissue, which alone increases the risk of breast cancer. Moreover, dense tissue can mask cancers on the mammogram, making screening more difficult.

Related Links:
Massachusetts Institute of Technology
Harvard Medical School


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.